When making changes after the product is on the market, potential risk is used to determine whether FDA approval is needed. A CBE$-30$ filing can be used for changes that are not high risk. Fill$-$in the following $2$ blanks:

If after submitting a CBE$-30$ to the FDA for changes to a product or process, a company has not heard any concerns from the FDA after $\_\_\_$A$\_\_\_$ days, then the company is allowed to$\_\_\_\_$B$\_\_\_\_\_$

Question $7$ options:

A: $60$ days, B:Proceed with the changes, or put your product on the market with the changes, etc. Basically $$ you are able to move forward without having to wait for FDA approval

A: $30$ days, B:Wait another $30$ days for the approval

A: $60$ days, B:Wait another $30$days for the approval

A: $30$ days, B:Proceed with the changes, or put your product on the market with the changes, etc. Basically $$ you are able to move forward without having to wait for FDA approval